Experimental colitis models: Insights into the pathogenesis of inflammatory bowel disease and translational issues

European Journal of Pharmacology

Volumn 759, Issue , 2015, Pages 253-264

  Valatas, Vassilis ^a   Bamias, Giorgos ^b   Kolios, George ^c  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Animal models; Crohn's disease; Experimental colitis; Inflammatory bowel disease; Translation; Ulcerative colitis

Indexed keywords

ANIMAL; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; INNATE IMMUNITY; INTESTINE MUCOSA; MUCOSAL IMMUNITY; PATHOLOGY; PROCEDURES; SPECIES DIFFERENCE; TRANSLATIONAL RESEARCH;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; SPECIES SPECIFICITY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84937759097     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.03.017     Document Type: Review

References (162)

1. C. Abraham, and J.H. Cho Inflammatory bowel disease N. Engl. J. Med. 361 2009 2066 2078
2. S. Akagi, E. Hiyama, Y. Imamura, Y. Takesue, Y. Matsuura, and T. Yokoyama Interleukin-10 expression in intestine of Crohn disease Int. J. Mol. Med. 5 2000 389 395
3. P. Alex, N.C. Zachos, T. Nguyen, L. Gonzales, T.E. Chen, L.S. Conklin, M. Centola, and X. Li Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis Inflamm. Bowel. Dis. 15 2009 341 352
4. F. Annunziato, L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Fili, S. Ferri, F. Frosali, F. Giudici, P. Romagnani, P. Parronchi, F. Tonelli, E. Maggi, and S. Romagnani Phenotypic and functional features of human Th17 cells J. Exp. Med. 204 2007 1849 1861
5. C. Asseman, S. Fowler, and F. Powrie Control of experimental inflammatory bowel disease by regulatory T cells Am J. Respir. Crit. Care Med. 162 2000 S185 189
6. R. Atreya, M. Zimmer, B. Bartsch, M.J. Waldner, I. Atreya, H. Neumann, K. Hildner, A. Hoffman, R. Kiesslich, A.D. Rink, T.T. Rau, S. Rose-John, H. Kessler, J. Schmidt, and M.F. Neurath Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14(+) macrophages Gastroenterology 141 2011 2026 2038
7. L.G. Axelsson, E. Landstrom, and A.C. Bylund-Fellenius Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine Aliment Pharmacol. Ther. 12 1998 925 934
8. G. Bamias, M.I. Dahman, K.O. Arseneau, M. Guanzon, D. Gruska, T.T. Pizarro, and F. Cominelli Intestinal-specific TNFalpha overexpression induces Crohn's-like ileitis in mice PLoS One 8 2013 e72594
9. G. Bamias, C. Martin, M. Mishina, W.G. Ross, J. Rivera-Nieves, M. Marini, and F. Cominelli Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation Gastroenterology 128 2005 654 666
10. G. Barbara, Z. Xing, C.M. Hogaboam, J. Gauldie, and S.M. Collins Interleukin 10 gene transfer prevents experimental colitis in rats Gut 46 2000 344 349
11. M.J. Barnes, and F. Powrie Regulatory T cells reinforce intestinal homeostasis Immunity 31 2009 401 411
12. C. Becker, H. Dornhoff, C. Neufert, M.C. Fantini, S. Wirtz, S. Huebner, A. Nikolaev, H.A. Lehr, A.J. Murphy, D.M. Valenzuela, G.D. Yancopoulos, P.R. Galle, M. Karow, and M.F. Neurath Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis J. Immunol. 177 2006 2760 2764
13. J. Beckwith, Y. Cong, J.P. Sundberg, C.O. Elson, and E.H. Leiter Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens Gastroenterology 129 2005 1473 1484
14. D.J. Berg, N. Davidson, R. Kuhn, W. Muller, S. Menon, G. Holland, L. Thompson-Snipes, M.W. Leach, and D. Rennick Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses J. Clin. Invest. 98 1996 1010 1020
15. M. Bjursten, P.W. Bland, R. Willen, and E.H. Hornquist Long-term treatment with anti-alpha 4 integrin antibodies aggravates colitis in G alpha i2-deficient mice Eur. J. Immunol. 35 2005 2274 2283
16. M. Boirivant, I.J. Fuss, A. Chu, and W. Strober Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4 J. Exp. Med. 188 1998 1929 1939
17. H. Braat, P. Rottiers, D.W. Hommes, N. Huyghebaert, E. Remaut, J.P. Remon, S.J. van Deventer, S. Neirynck, M.P. Peppelenbosch, and L. Steidler A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease Clin Gastroenterol Hepatol 4 2006 754 759
18. O. Brain, B.M. Owens, T. Pichulik, P. Allan, E. Khatamzas, A. Leslie, T. Steevels, S. Sharma, A. Mayer, A.M. Catuneanu, V. Morton, M.Y. Sun, D. Jewell, M. Coccia, O. Harrison, K. Maloy, S. Schonefeldt, S. Bornschein, A. Liston, and A. Simmons The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release Immunity 39 2013 521 536
19. M.C. Braun, E. Lahey, and B.L. Kelsall Selective suppression of IL-12 production by chemoattractants J. Immunol. 164 2000 3009 3017
20. J.B. Brown, G. Lee, E. Managlia, G.R. Grimm, R. Dirisina, T. Goretsky, P. Cheresh, N.R. Blatner, K. Khazaie, G.Y. Yang, L. Li, and T.A. Barrett Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis Gastroenterology 138 2010 595 605 605.e591-593
21. S. Buonocore, P.P. Ahern, H.H. Uhlig, II Ivanov, D.R. Littman, K.J. Maloy, and F. Powrie Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology Nature 464 2010 1371 1375
22. R.C. Burns, J. Rivera-Nieves, C.A. Moskaluk, S. Matsumoto, F. Cominelli, and K. Ley Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice Gastroenterology 121 2001 1428 1436
23. F.E. Buruiana, I. Sola, and P. Alonso-Coello Recombinant human interleukin 10 for induction of remission in Crohn's disease Cochrane Database Syst. Rev. 2010 Cd005109
24. K. Cadwell, J.Y. Liu, S.L. Brown, H. Miyoshi, J. Loh, J.K. Lennerz, C. Kishi, W. Kc, J.A. Carrero, S. Hunt, C.D. Stone, E.M. Brunt, R.J. Xavier, B.P. Sleckman, E. Li, N. Mizushima, T.S. Stappenbeck, and H.W.t. Virgin A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells Nature 456 2008 259 263
25. K. Cadwell, K.K. Patel, N.S. Maloney, T.C. Liu, A.C. Ng, C.E. Storer, R.D. Head, R. Xavier, T.S. Stappenbeck, and H.W. Virgin Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine Cell 141 2010 1135 1145
26. A. Collett, N.B. Higgs, M. Gironella, L.A. Zeef, A. Hayes, E. Salmo, N. Haboubi, J.L. Iovanna, G.L. Carlson, and G. Warhurst Early molecular and functional changes in colonic epithelium that precede increased gut permeability during colitis development in mdr1a(-/-) mice Inflamm. Bowel. Dis. 14 2008 620 631
27. R. Cooney, J. Baker, O. Brain, B. Danis, T. Pichulik, P. Allan, D.J. Ferguson, B.J. Campbell, D. Jewell, and A. Simmons NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation Nat. Med. 16 2010 90 97
28. A. Couturier-Maillard, T. Secher, A. Rehman, S. Normand, A. De Arcangelis, R. Haesler, L. Huot, T. Grandjean, A. Bressenot, A. Delanoye-Crespin, O. Gaillot, S. Schreiber, Y. Lemoine, B. Ryffel, D. Hot, G. Nunez, G. Chen, P. Rosenstiel, and M. Chamaillard NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer J. Clin. Invest. 123 2013 700 711
29. H. Dalwadi, B. Wei, M. Schrage, K. Spicher, T.T. Su, L. Birnbaumer, D.J. Rawlings, and J. Braun B cell developmental requirement for the G alpha i2 gene J. Immunol. 170 2003 1707 1715
30. Danese, S., Rudzinski, J., Brandt, W., Dupas, J.L., Peyrin-Biroulet, L., Bouhnik, Y., Kleczkowski, D., Uebel, P., Lukas, M., Knutsson, M., Erlandsson, F., Berner Hansen, M., Keshav, S., 2014. Tralokinumab (CAT-354), an interleukin 13 antibody, in moderate to severe ulcerative colitis: A phase 2 randomized placebo-controlled study., In: Proceedings of the 9th Congress of ECCO, Copenhagen.
31. C. Daniel, N.A. Sartory, N. Zahn, H.H. Radeke, and J.M. Stein Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile J. Pharmacol. Exp. Ther. 324 2008 23 33
32. N.J. Davidson, S.A. Hudak, R.E. Lesley, S. Menon, M.W. Leach, and D.M. Rennick IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice J. Immunol. 161 1998 3143 3149
33. P. Desreumaux, A. Foussat, M. Allez, L. Beaugerie, X. Hebuterne, Y. Bouhnik, M. Nachury, V. Brun, H. Bastian, N. Belmonte, M. Ticchioni, A. Duchange, P. Morel-Mandrino, V. Neveu, N. Clerget-Chossat, M. Forte, and J.F. Colombel Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease Gastroenterology 143 2012 1207 1217 e1201-1202
34. J. Dumortier, M.G. Lapalus, O. Guillaud, G. Poncet, M.C. Gagnieu, C. Partensky, and J.Y. Scoazec Everolimus for refractory Crohn's disease: a case report Inflamm. Bowel. Dis. 14 2008 874 877
35. R. Ehehalt, A. Braun, M. Karner, J. Fullekrug, and W. Stremmel Phosphatidylcholine as a constituent in the colonic mucosal barrier - physiological and clinical relevance Biochim. Biophys. Acta 1801 2010 983 993
36. A.W. Einerhand, I.B. Renes, M.K. Makkink, M. van der Sluis, H.A. Buller, and J. Dekker Role of mucins in inflammatory bowel disease: important lessons from experimental models Eur. J. Gastroenterol. Hepatol. 14 2002 757 765
37. S. Farkas, M. Hornung, C. Sattler, K. Edtinger, M. Steinbauer, M. Anthuber, H.J. Schlitt, H. Herfarth, and E.K. Geissler Blocking MAdCAM-1 in vivo reduces leukocyte extravasation and reverses chronic inflammation in experimental colitis Int. J. Colorectal Dis. 21 2006 71 78
38. R.N. Fedorak, A. Gangl, C.O. Elson, P. Rutgeerts, S. Schreiber, G. Wild, S.B. Hanauer, A. Kilian, M. Cohard, A. LeBeaut, and B. Feagan Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group Gastroenterology 119 2000 1473 1482
39. S. Fichtner-Feigl, I.J. Fuss, C.A. Young, T. Watanabe, E.K. Geissler, H.J. Schlitt, A. Kitani, and W. Strober Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis J. Immunol. 178 2007 5859 5870
40. S. Fichtner-Feigl, R. Kesselring, M. Martin, F. Obermeier, P. Ruemmele, A. Kitani, S.M. Brunner, M. Haimerl, E.K. Geissler, W. Strober, and H.J. Schlitt IL-13 orchestrates resolution of chronic intestinal inflammation via phosphorylation of glycogen synthase kinase-3beta J. Immunol. 192 2014 3969 3980
41. S. Fiorucci, J.L. Wallace, A. Mencarelli, E. Distrutti, G. Rizzo, S. Farneti, A. Morelli, J.L. Tseng, B. Suramanyam, W.J. Guilford, and J.F. Parkinson A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction Proc. Natl. Acad. Sci. USA 101 2004 15736 15741
42. J.D. Fontenot, J.P. Rasmussen, M.A. Gavin, and A.Y. Rudensky A function for interleukin 2 in Foxp3-expressing regulatory T cells Nat. Immunol. 6 2005 1142 1151
43. I.J. Fuss, F. Heller, M. Boirivant, F. Leon, M. Yoshida, S. Fichtner-Feigl, Z. Yang, M. Exley, A. Kitani, R.S. Blumberg, P. Mannon, and W. Strober Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis J. Clin. Invest. 113 2004 1490 1497
44. I.J. Fuss, T. Marth, M.F. Neurath, G.R. Pearlstein, A. Jain, and W. Strober Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice Gastroenterology 117 1999 1078 1088
45. W.S. Garrett, G.M. Lord, S. Punit, G. Lugo-Villarino, S.K. Mazmanian, S. Ito, J.N. Glickman, and L.H. Glimcher Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system Cell 131 2007 33 45
46. N. Gassler, C. Rohr, A. Schneider, J. Kartenbeck, A. Bach, N. Obermuller, H.F. Otto, and F. Autschbach Inflammatory bowel disease is associated with changes of enterocytic junctions Am. J. Physiol. Gastrointest. Liver Physiol. 281 2001 G216 228
47. L. Gillberg, S. Berg, P.J. de Verdier, L. Lindbom, J. Werr, and P.M. Hellstrom Effective treatment of mouse experimental colitis by alpha 2 integrin antibody: comparison with alpha 4 antibody and conventional therapy Acta Physiol (Oxf) 207 2013 326 336
48. L. Gorelik, and R.A. Flavell Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease Immunity 12 2000 171 181
49. Y.Y. Gotlind, S. Raghavan, P.W. Bland, and E.H. Hornquist CD4+FoxP3+ regulatory T cells from Galphai2-/- mice are functionally active in vitro, but do not prevent colitis PLoS One 6 2011 e25073
50. D.G. Hackam, and D.A. Redelmeier Translation of research evidence from animals to humans JAMA 296 2006 1731 1732
51. L. Halme, P. Paavola-Sakki, U. Turunen, M. Lappalainen, M. Farkkila, and K. Kontula Family and twin studies in inflammatory bowel disease World J. Gastroenterol. 12 2006 3668 3672
52. L.E. Harrington, R.D. Hatton, P.R. Mangan, H. Turner, T.L. Murphy, K.M. Murphy, and C.T. Weaver Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat. Immunol. 6 2005 1123 1132
53. J. He, S. Gurunathan, A. Iwasaki, B. Ash-Shaheed, and B.L. Kelsall Primary role for Gi protein signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses J. Exp. Med. 191 2000 1605 1610
54. F. Heller, I.J. Fuss, E.E. Nieuwenhuis, R.S. Blumberg, and W. Strober Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells Immunity 17 2002 629 638
55. M.L. Hermiston, and J.I. Gordon Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin Science 270 1995 1203 1207
56. M.E. Himmel, Y. Yao, P.C. Orban, T.S. Steiner, and M.K. Levings Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers Immunology 136 2012 115 122
57. G.A. Hollander, S.J. Simpson, E. Mizoguchi, A. Nichogiannopoulou, J. She, J.C. Gutierrez-Ramos, A.K. Bhan, S.J. Burakoff, B. Wang, and C. Terhorst Severe colitis in mice with aberrant thymic selection Immunity 3 1995 27 38
58. J.C. Hoving, F. Kirstein, N.E. Nieuwenhuizen, L.C. Fick, E. Hobeika, M. Reth, and F. Brombacher B cells that produce immunoglobulin E mediate colitis in BALB/c mice Gastroenterology 142 2012 96 108
59. S. Hue, P. Ahern, S. Buonocore, M.C. Kullberg, D.J. Cua, B.S. McKenzie, F. Powrie, and K.J. Maloy Interleukin-23 drives innate and T cell-mediated intestinal inflammation J. Exp. Med. 203 2006 2473 2483
60. W. Hueber, B.E. Sands, S. Lewitzky, M. Vandemeulebroecke, W. Reinisch, P.D. Higgins, J. Wehkamp, B.G. Feagan, M.D. Yao, M. Karczewski, J. Karczewski, N. Pezous, S. Bek, G. Bruin, B. Mellgard, C. Berger, M. Londei, A.P. Bertolino, G. Tougas, and S.P. Travis Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial Gut 61 2012 1693 1700
61. J.P. Hugot, M. Chamaillard, H. Zouali, S. Lesage, J.P. Cezard, J. Belaiche, S. Almer, C. Tysk, C.A. O'Morain, M. Gassull, V. Binder, Y. Finkel, A. Cortot, R. Modigliani, P. Laurent-Puig, C. Gower-Rousseau, J. Macry, J.F. Colombel, M. Sahbatou, and G. Thomas Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 2001 599 603
62. W. Jiang, X. Wang, B. Zeng, L. Liu, A. Tardivel, H. Wei, J. Han, H.R. MacDonald, J. Tschopp, Z. Tian, and R. Zhou Recognition of gut microbiota by NOD2 is essential for the homeostasis of intestinal intraepithelial lymphocytes J. Exp. Med. 210 2013 2465 2476
63. M.E. Johansson, H. Sjovall, and G.C. Hansson The gastrointestinal mucus system in health and disease Nat. Rev. Gastroenterol. Hepatol. 10 2013 352 361
64. N. Kamada, S.U. Seo, G.Y. Chen, and G. Nunez Role of the gut microbiota in immunity and inflammatory disease Nat. Rev. Immunol. 13 2013 321 335
65. M. Karner, A. Kocjan, J. Stein, S. Schreiber, G. von Boyen, P. Uebel, C. Schmidt, L. Kupcinskas, I. Dina, F. Zuelch, G. Keilhauer, and W. Stremmel First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses Am. J. Gastroenterol. 2014
66. S. Kato, R. Hokari, K. Matsuzaki, A. Iwai, A. Kawaguchi, S. Nagao, T. Miyahara, K. Itoh, H. Ishii, and S. Miura Amelioration of murine experimental colitis by inhibition of mucosal addressin cell adhesion molecule-1 J. Pharmacol. Exp. Ther. 295 2000 183 189
67. B. Khor, A. Gardet, and R.J. Xavier Genetics and pathogenesis of inflammatory bowel disease Nature 474 2011 307 317
68. J.B. Kirsner, and J. Elchlepp The production of an experimental ulcerative colitis in rabbits Trans. Assoc. Am. Physicians 70 1957 102 119
69. K.S. Kobayashi, M. Chamaillard, Y. Ogura, O. Henegariu, N. Inohara, G. Nunez, and R.A. Flavell Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract Science 307 2005 731 734
70. M. Kobayashi, M.N. Kweon, H. Kuwata, R.D. Schreiber, H. Kiyono, K. Takeda, and S. Akira Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice J. Clin. Invest. 111 2003 1297 1308
71. R. Kojima, S. Kuroda, T. Ohkishi, K. Nakamaru, and S. Hatakeyama Oxazolone-induced colitis in BALB/C mice: a new method to evaluate the efficacy of therapeutic agents for ulcerative colitis J. Pharmacol. Sci. 96 2004 307 313
72. G. Kojouharoff, W. Hans, F. Obermeier, D.N. Mannel, T. Andus, J. Scholmerich, V. Gross, and W. Falk Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice Clin. Exp. Immunol. 107 1997 353 358
73. D. Kontoyiannis, G. Boulougouris, M. Manoloukos, M. Armaka, M. Apostolaki, T. Pizarro, A. Kotlyarov, I. Forster, R. Flavell, M. Gaestel, P. Tsichlis, F. Cominelli, and G. Kollias Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease J. Exp. Med. 196 2002 1563 1574
74. D. Kontoyiannis, M. Pasparakis, T.T. Pizarro, F. Cominelli, and G. Kollias Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies Immunity 10 1999 387 398
75. M.M. Kosiewicz, C.C. Nast, A. Krishnan, J. Rivera-Nieves, C.A. Moskaluk, S. Matsumoto, K. Kozaiwa, and F. Cominelli Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease J. Clin. Invest. 107 2001 695 702
76. S. Kugathasan, L.J. Saubermann, L. Smith, D. Kou, J. Itoh, D.G. Binion, A.D. Levine, R.S. Blumberg, and C. Fiocchi Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease Gut 56 2007 1696 1705
77. M.C. Kullberg, D. Jankovic, C.G. Feng, S. Hue, P.L. Gorelick, B.S. McKenzie, D.J. Cua, F. Powrie, A.W. Cheever, K.J. Maloy, and A. Sher IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis J. Exp. Med. 203 2006 2485 2494
78. M.C. Kullberg, A.G. Rothfuchs, D. Jankovic, P. Caspar, T.A. Wynn, P.L. Gorelick, A.W. Cheever, and A. Sher Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation Infect. Immun. 69 2001 4232 4241
79. M. Kverka, P. Rossmann, H. Tlaskalova-Hogenova, K. Klimesova, B. Jharap, N.K. de Boer, R.M. Vos, A.A. van Bodegraven, M. Lukas, and C.J. Mulder Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis BMC Gastroenterol. 11 2011 47
80. E.G. Lee, D.L. Boone, S. Chai, S.L. Libby, M. Chien, J.P. Lodolce, and A. Ma Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice Science 289 2000 2350 2354
81. R.E. Ley, F. Backhed, P. Turnbaugh, C.A. Lozupone, R.D. Knight, and J.I. Gordon Obesity alters gut microbial ecology Proc. Natl. Acad. Sci. USA 102 2005 11070 11075
82. X. Li, J.G. Fox, M.T. Whary, L. Yan, B. Shames, and Z. Zhao SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis Infect. Immun. 66 1998 5477 5484
83. M.J. Lodes, Y. Cong, C.O. Elson, R. Mohamath, C.J. Landers, S.R. Targan, M. Fort, and R.M. Hershberg Bacterial flagellin is a dominant antigen in Crohn disease J. Clin. Invest. 113 2004 1296 1306
84. S. Maeda, L.C. Hsu, H. Liu, L.A. Bankston, M. Iimura, M.F. Kagnoff, L. Eckmann, and M. Karin Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing Science 307 2005 734 738
85. M. Mahler, I.J. Bristol, E.H. Leiter, A.E. Workman, E.H. Birkenmeier, C.O. Elson, and J.P. Sundberg Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis Am. J. Physiol. 274 1998 G544 551
86. M. Marini, G. Bamias, J. Rivera-Nieves, C.A. Moskaluk, S.B. Hoang, W.G. Ross, T.T. Pizarro, and F. Cominelli TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis Proc. Natl. Acad. Sci. USA 100 2003 8366 8371
87. G.J. Marlow, D. van Gent, and L.R. Ferguson Why interleukin-10 supplementation does not work in Crohn's disease patients World J. Gastroenterol. 19 2013 3931 3941
88. D.C. Massey, F. Bredin, and M. Parkes Use of sirolimus (rapamycin) to treat refractory Crohn's disease Gut 57 2008 1294 1296
89. K. Matsuzaki, Y. Tsuzuki, H. Matsunaga, T. Inoue, J. Miyazaki, R. Hokari, Y. Okada, A. Kawaguchi, S. Nagao, K. Itoh, S. Matsumoto, and S. Miura In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1 Clin. Exp. Immunol. 140 2005 22 31
90. J. Maul, C. Loddenkemper, P. Mundt, E. Berg, T. Giese, A. Stallmach, M. Zeitz, and R. Duchmann Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease Gastroenterology 128 2005 1868 1878
91. S. Melgar, L. Karlsson, E. Rehnstrom, A. Karlsson, H. Utkovic, L. Jansson, and E. Michaelsson Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease Int. Immunopharmacol. 8 2008 836 844
92. S. Melgar, M.M. Yeung, A. Bas, G. Forsberg, O. Suhr, A. Oberg, S. Hammarstrom, A. Danielsson, and M.L. Hammarstrom Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis Clin. Exp. Immunol. 134 2003 127 137
93. A. Mizoguchi, and E. Mizoguchi Inflammatory bowel disease, past, present and future: lessons from animal models J. Gastroenterol. 43 2008 1 17
94. A. Mizoguchi, E. Mizoguchi, C. Chiba, G.M. Spiekermann, S. Tonegawa, C. Nagler-Anderson, and A.K. Bhan Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease J. Exp. Med. 183 1996 847 856
95. K.W. Moore, A. O'Garra, R. de Waal Malefyt, P. Vieira, and T.R. Mosmann Interleukin-10 Annu. Rev. Immunol. 11 1993 165 190
96. S. Nakae, Y. Iwakura, H. Suto, and S.J. Galli Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17 J. Leukoc. Biol. 81 2007 1258 1268
97. A. Nenci, C. Becker, A. Wullaert, R. Gareus, G. van Loo, S. Danese, M. Huth, A. Nikolaev, C. Neufert, B. Madison, D. Gumucio, M.F. Neurath, and M. Pasparakis Epithelial NEMO links innate immunity to chronic intestinal inflammation Nature 446 2007 557 561
98. M.F. Neurath, I. Fuss, B.L. Kelsall, E. Stuber, and W. Strober Antibodies to interleukin 12 abrogate established experimental colitis in mice J. Exp. Med. 182 1995 1281 1290
99. M.F. Neurath, I. Fuss, M. Pasparakis, L. Alexopoulou, S. Haralambous, K.H. Meyer zum Buschenfelde, W. Strober, and G. Kollias Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice Eur. J. Immunol. 27 1997 1743 1750
100. O.H. Nielsen, and M.A. Ainsworth Tumor necrosis factor inhibitors for inflammatory bowel disease N. Engl. J. Med. 369 2013 754 762
101. A. Nishida, C.W. Lau, M. Zhang, A. Andoh, H.N. Shi, E. Mizoguchi, and A. Mizoguchi The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice Gastroenterology 142 2012 865 874 e862
102. E. Noguchi, Y. Homma, X. Kang, M.G. Netea, and X. Ma A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1 Nat. Immunol. 10 2009 471 479
103. W. O'Connor Jr., M. Kamanaka, C.J. Booth, T. Town, S. Nakae, Y. Iwakura, J.K. Kolls, and R.A. Flavell A protective function for interleukin 17A in T cell-mediated intestinal inflammation Nat. Immunol. 10 2009 603 609
104. F. Obermeier, G. Kojouharoff, W. Hans, J. Scholmerich, V. Gross, and W. Falk Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice Clin. Exp. Immunol. 116 1999 238 245
105. L. Ohman, R.G. Astrom, and E. Hultgren Hornquist Impaired B cell responses to orally administered antigens in lamina propria but not Peyer's patches of Galphai2-deficient mice prior to colitis Immunology 115 2005 271 278
106. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 98 1990 694 702
107. T.S. Olson, B.K. Reuter, K.G. Scott, M.A. Morris, X.M. Wang, L.N. Hancock, T.L. Burcin, S.M. Cohn, P.B. Ernst, F. Cominelli, J.B. Meddings, K. Ley, and T.T. Pizarro The primary defect in experimental ileitis originates from a nonhematopoietic source J. Exp. Med. 203 2006 541 552
108. C.M. Panwala, J.C. Jones, and J.L. Viney A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis J. Immunol. 161 1998 5733 5744
109. L. Pastorelli, C. De Salvo, J.R. Mercado, M. Vecchi, and T.T. Pizarro Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics Front Immunol. 4 2013 280
110. M. Peeters, B. Geypens, D. Claus, H. Nevens, Y. Ghoos, G. Verbeke, F. Baert, S. Vermeire, R. Vlietinck, and P. Rutgeerts Clustering of increased small intestinal permeability in families with Crohn's disease Gastroenterology 113 1997 802 807
111. D. Picarella, P. Hurlbut, J. Rottman, X. Shi, E. Butcher, and D.J. Ringler Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells J. Immunol. 158 1997 2099 2106
112. T.S. Plantinga, T.O. Crisan, M. Oosting, F.L. van de Veerdonk, D.J. de Jong, D.J. Philpott, J.W. van der Meer, S.E. Girardin, L.A. Joosten, and M.G Netea Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2 Gut 60 2011 1229 1235
113. L.S. Poritz, K.I. Garver, C. Green, L. Fitzpatrick, F. Ruggiero, and W.A. Koltun Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis J. Surg. Res. 140 2007 12 19
114. F. Powrie, M.W. Leach, S. Mauze, L.B. Caddle, and R.L. Coffman Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice Int. Immunol. 5 1993 1461 1471
115. F. Powrie, M.W. Leach, S. Mauze, S. Menon, L.B. Caddle, and R.L. Coffman Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells Immunity 1 1994 553 562
116. G.L. Radice N-cadherin-mediated adhesion and signaling from development to disease: lessons from mice Prog. Mol. Biol. Transl. Sci. 116 2013 263 289
117. S. Rakoff-Nahoum, J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis Cell 118 2004 229 241
118. W. Reinisch, W. de Villiers, L. Bene, L. Simon, I. Racz, S. Katz, I. Altorjay, B. Feagan, D. Riff, C.N. Bernstein, D. Hommes, P. Rutgeerts, A. Cortot, M. Gaspari, M. Cheng, T. Pearce, and B.E. Sands Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study Inflamm. Bowel. Dis. 16 2010 233 242
119. W. Reinisch, J. Panes, M. Lemann, S. Schreiber, B. Feagan, S. Schmidt, G.C. Sturniolo, T. Mikhailova, O. Alexeeva, L. Sanna, T. Haas, S. Korom, and H. Mayer A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease Am J. Gastroenterol. 103 2008 2284 2292
120. D.M. Rennick, M.M. Fort, and N.J. Davidson Studies with IL-10-/- mice: an overview J. Leukoc. Biol. 61 1997 389 396
121. J. Rivera-Nieves, G. Bamias, A. Vidrich, M. Marini, T.T. Pizarro, M.J. McDuffie, C.A. Moskaluk, S.M. Cohn, and F. Cominelli Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis Gastroenterology 124 2003 972 982
122. J. Rivera-Nieves, T. Olson, G. Bamias, A. Bruce, M. Solga, R.F. Knight, S. Hoang, F. Cominelli, and K. Ley L-selectin, alpha 4 beta 1, and alpha 4 beta 7 integrins participate in CD4+ T cell recruitment to chronically inflamed small intestine J. Immunol. 174 2005 2343 2352
123. M. Roulis, M. Armaka, M. Manoloukos, M. Apostolaki, and G. Kollias Intestinal epithelial cells as producers but not targets of chronic TNF suffice to cause murine Crohn-like pathology Proc. Natl. Acad. Sci. USA 108 2011 5396 5401
124. U. Rudolph, M.J. Finegold, S.S. Rich, G.R. Harriman, Y. Srinivasan, P. Brabet, G. Boulay, A. Bradley, and L. Birnbaumer Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice Nat. Genet. 10 1995 143 150
125. T. Saitoh, N. Fujita, M.H. Jang, S. Uematsu, B.G. Yang, T. Satoh, H. Omori, T. Noda, N. Yamamoto, M. Komatsu, K. Tanaka, T. Kawai, T. Tsujimura, O. Takeuchi, T. Yoshimori, and S. Akira Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production Nature 456 2008 264 268
126. M. Saruta, Q.T. Yu, P.R. Fleshner, P.Y. Mantel, C.B. Schmidt-Weber, A.H. Banham, and K.A. Papadakis Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease Clin. Immunol. 125 2007 281 290
127. S. Schreiber, R.N. Fedorak, O.H. Nielsen, G. Wild, C.N. Williams, S. Nikolaus, M. Jacyna, B.A. Lashner, A. Gangl, P. Rutgeerts, K. Isaacs, S.J. van Deventer, J.C. Koningsberger, M. Cohard, A. LeBeaut, and S.B. Hanauer Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group Gastroenterology 119 2000 1461 1472
128. S. Schreiber, T. Heinig, H.G. Thiele, and A. Raedler Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease Gastroenterology 108 1995 1434 1444
129. N. Selve, and T. Wohrmann Intestinal inflammation in TNBS sensitized rats as a model of chronic inflammatory bowel disease Mediat. Inflamm. 1 1992 121 126
130. M.M. Shull, I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, and D. Calvin Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease Nature 359 1992 693 699
131. S.I. Siakavellas, and G. Bamias Role of the IL-23/IL-17 axis in Crohn's disease Discov. Med. 14 2012 253 262
132. L.A. Simms, J.D. Doecke, M.D. Walsh, N. Huang, E.V. Fowler, and G.L. Radford-Smith Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease Gut 57 2008 903 910
133. W.G. Smalley-Freed, A. Efimov, P.E. Burnett, S.P. Short, M.A. Davis, D.L. Gumucio, M.K. Washington, R.J. Coffey, and A.B. Reynolds p120-catenin is essential for maintenance of barrier function and intestinal homeostasis in mice J. Clin. Invest. 120 2010 1824 1835
134. A. Soriano, A. Salas, A. Salas, M. Sans, M. Gironella, M. Elena, D.C. Anderson, J.M. Pique, and J. Panes VCAM-1, but not ICAM-1 or MAdCAM-1, immunoblockade ameliorates DSS-induced colitis in mice Lab. Invest. 80 2000 1541 1551
135. D.M. Spencer, G.M. Veldman, S. Banerjee, J. Willis, and A.D. Levine Distinct inflammatory mechanisms mediate early versus late colitis in mice Gastroenterology 122 2002 94 105
136. W. Strober, and I.J. Fuss Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases Gastroenterology 140 2011 1756 1767
137. S. Sudarsanam, and D.E. Johnson Functional consequences of mTOR inhibition Curr. Opin. Drug. Discov. Dev. 13 2010 31 40
138. J.P. Sundberg, C.O. Elson, H. Bedigian, and E.H. Birkenmeier Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice Gastroenterology 107 1994 1726 1735
139. A. Swidsinski, A. Ladhoff, A. Pernthaler, S. Swidsinski, V. Loening-Baucke, M. Ortner, J. Weber, U. Hoffmann, S. Schreiber, M. Dietel, and H. Lochs Mucosal flora in inflammatory bowel disease Gastroenterology 122 2002 44 54
140. K. Takeda, B.E. Clausen, T. Kaisho, T. Tsujimura, N. Terada, I. Forster, and S. Akira Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils Immunity 10 1999 39 49
141. S.R. Targan, B.G. Feagan, S. Vermeire, R. Panaccione, G.Y. Melmed, C. Blosch, R. Newmark, N. Zhang, Y. Chon, S.-L. Lin, and P. Klekotka Mo2083 A randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and efficacy of AMG 827 in subjects with moderate to severe Crohn's disease Gastroenterology 143 2012 e26
142. K. Teramoto, S. Miura, Y. Tsuzuki, R. Hokari, C. Watanabe, T. Inamura, T. Ogawa, N. Hosoe, H. Nagata, H. Ishii, and T. Hibi Increased lymphocyte trafficking to colonic microvessels is dependent on MAdCAM-1 and C-C chemokine mLARC/CCL20 in DSS-induced mice colitis Clin. Exp. Immunol. 139 2005 421 428
143. E. Thachil, J.P. Hugot, B. Arbeille, R. Paris, A. Grodet, M. Peuchmaur, P. Codogno, F. Barreau, E. Ogier-Denis, D. Berrebi, and J. Viala Abnormal activation of autophagy-induced crinophagy in Paneth cells from patients with Crohn's disease Gastroenterology 142 2012 1097 1099 e1094
144. C.K. Tsang, H. Qi, L.F. Liu, and X.F. Zheng Targeting mammalian target of rapamycin (mTOR) for health and diseases Drug Discov. Today 12 2007 112 124
145. P.J. Turnbaugh, V.K. Ridaura, J.J. Faith, F.E. Rey, R. Knight, and J.I. Gordon The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice Sci. Transl. Med. 1 2009 6ra14
146. H.H. Uhlig, B.S. McKenzie, S. Hue, C. Thompson, B. Joyce-Shaikh, R. Stepankova, N. Robinson, S. Buonocore, H. Tlaskalova-Hogenova, D.J. Cua, and F. Powrie Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology Immunity 25 2006 309 318
147. V. Valatas, J. He, A. Rivollier, G. Kolios, K. Kitamura, and B.L. Kelsall Host-dependent control of early regulatory and effector T-cell differentiation underlies the genetic susceptibility of RAG2-deficient mouse strains to transfer colitis Mucosal. Immunol. 6 2013 601 611
148. V. Valatas, M. Vakas, and G. Kolios The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases Am. J. Physiol. Gastrointest. Liver Physiol. 305 2013 G763 785
149. M. Van der Sluis, B.A. De Koning, A.C. De Bruijn, A. Velcich, J.P. Meijerink, J.B. Van Goudoever, H.A. Buller, J. Dekker, I. Van Seuningen, I.B. Renes, and A.W. Einerhand Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection Gastroenterology 131 2006 117 129
150. H.B. van der Worp, D.W. Howells, E.S. Sena, M.J. Porritt, S. Rewell, V. O'Collins, and M.R. Macleod Can animal models of disease reliably inform human studies? PLoS Med. 7 2010 e1000245
151. S.J. van Deventer, C.O. Elson, and R.N. Fedorak Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group Gastroenterology 113 1997 383 389
152. C. Veltkamp, R.B. Sartor, T. Giese, F. Autschbach, I. Kaden, R. Veltkamp, D. Rost, B. Kallinowski, and W. Stremmel Regulatory CD4+CD25+ cells reverse imbalances in the T cell pool of bone marrow transplanted TGepsilon26 mice leading to the prevention of colitis Gut 54 2005 207 214
153. S. Vermeire, P.J. Rutgeerts, G.R. D'Haens, M. De Vos, B. Bressler, A. Van der Aa, B. Coulie, C.J. Wong, and B.G. Feagan 46 A phase 2a randomized placebo-controlled double-blind multi-center dose escalation study to evaluate the safety, tolerability, pharmacodynamics and efficacy of AG011 in patients with moderately active ulcerative colitis Gastroenterology 138 2010 S-9
154. A.C. Vos, M.E. Wildenberg, M. Duijvestein, A.P. Verhaar, G.R. van den Brink, and D.W. Hommes Anti-tumor necrosis factor-alpha antibodies induce regulatory macrophages in an Fc region-dependent manner Gastroenterology 140 2011 221 230
155. T. Watanabe, A. Kitani, P.J. Murray, and W. Strober NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses Nat. Immunol. 5 2004 800 808
156. D.M. Willerford, J. Chen, J.A. Ferry, L. Davidson, A. Ma, and F.W. Alt Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment Immunity 3 1995 521 530
157. S. Wirtz, S. Finotto, S. Kanzler, A.W. Lohse, M. Blessing, H.A. Lehr, P.R. Galle, and M.F. Neurath Cutting edge: chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens J. Immunol. 162 1999 1884 1888
158. J.Y. Wu, Y. Jin, R.A. Edwards, Y. Zhang, M.J. Finegold, and M.X. Wu Impaired TGF-beta responses in peripheral T cells of G alpha i2-/- mice J. Immunol. 174 2005 6122 6128
159. A. Yamamoto, T. Itoh, R. Nasu, and R. Nishida Effect of sodium alginate on dextran sulfate sodium- and 2,4,6-trinitrobenzene sulfonic acid-induced experimental colitis in mice Pharmacology 92 2013 108 116
160. X.O. Yang, S.H. Chang, H. Park, R. Nurieva, B. Shah, L. Acero, Y.H. Wang, K.S. Schluns, R.R. Broaddus, Z. Zhu, and C. Dong Regulation of inflammatory responses by IL-17F J. Exp. Med. 205 2008 1063 1075
161. D. Yen, J. Cheung, H. Scheerens, F. Poulet, T. McClanahan, B. McKenzie, M.A. Kleinschek, A. Owyang, J. Mattson, W. Blumenschein, E. Murphy, M. Sathe, D.J. Cua, R.A. Kastelein, and D. Rennick IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 J. Clin. Invest. 116 2006 1310 1316
162. Q.T. Yu, M. Saruta, A. Avanesyan, P.R. Fleshner, A.H. Banham, and K.A. Papadakis Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis Inflamm. Bowel. Dis. 13 2007 191 199